NZ Approval for LCT Clinical Trials now Final

[ Follow-Ups ] [ Post Followup ] [ The Islet Foundation Public Message Forum ]

Posted by Medical News on 09:03:30 2009/06/24

Your browser does not support inline frames, or it has been configured incorrectly. If page does not display on your browser, please <a href="http://www.news-medical.net/news/20090623/Clinical-trial-raises-hope-for-Australian-diabetics-to-be-insulin-free.aspx">CLICK HERE</a>. GS_googleAddAdSenseService("ca-pub-8430344808469242"); GS_googleEnableAllServices(); GA_googleAddSlot("ca-pub-8430344808469242", "News-Medical728x90Top"); GA_googleAddSlot("ca-pub-8430344808469242", "News-Medical728x90Bottom"); GA_googleAddSlot("ca-pub-8430344808469242", "News-Medical160x600Towers"); GA_googleAddSlot("ca-pub-8430344808469242", "NewsMedicalSquares"); GA_googleFetchAds(); function google_ad_request_done(google_ads) { if (google_ads.length Clinical trial raises hope for Australian diabetics to be insulin free THE MEDICAL NEWS from News-Medical.Net - Latest Medical News and Research from Around the World GA_googleFillSlot("News-Medical728x90Top"); Home | Child Health News | Disease/Infection News | Drug Trial News | Healthcare News | Medical Condition News | Medical Device News | Medical Patent News | Medical Procedure News | Medical Research News | Medical Science News | Men's Health News | Miscellaneous News | Pharmaceutical News | Women's Health News | Archive | Medical A to Z | Newsletters | Blogs | Forums | Twitter | Subscribe // // google_ad_client = "pub-8430344808469242"; google_alternate_ad_url = "http://www.news-medical.net/images/spacer.gif"; google_ad_channel = "4203283877"; google_ad_output = "js"; google_max_num_ads = 12; google_ad_type = "text_image"; google_color_line = "330000"; google_feedback = 'on'; Recent Comments Potential stem cells treatment for retinitis pigmentosa and other retinal degenerations (9) mohamed wrote: Dear doctors, I am 46 years old and was born with … [More] Blood clots after hip and knee replacements (1) Sue wrote: Blood clots can lead to many health complicatons i… [More] Mentally ill endure lives of loneliness and exclusion (1) Val wrote: My name is Val I live in Seattle Washington. I hav… [More] New guidelines on non-muscle invasive bladder cancer (1) Z . A. SHAH. MD., retired. wrote: US FDA approved biomarkers for BLC are becoming Go… [More] Frank, Dodd, Grassley speak their minds (1) jacksmith wrote: It’s official. America and the World are now in a … [More] Benfotiamene, a fat-soluble form of vitamin B1, could treat common cause of blindness (1) k.kumar wrote: It is marvelous indeed that PROF RAMANA OF UTMB is… [More] Questions raised over Australia's first swine flu related death (1) gavin couzens wrote: Being infected during transportation to hospital s… [More] Comment RSS Twitter Follow us on Twitter Information Information Medical News Letters Medical News 'Tweets' Terms and Conditions << Scientists block Ebola infection in cell-culture experiments - could lead to first therapy | Federal Minister for Health to launch Australia’s first national maternity surveillance system >> Clinical trial raises hope for Australian diabetics to be insulin free 23. June 2009 20:52 GA_googleFillSlot("NewsMedicalSquares"); A clinical trial for a new treatment for type 1 diabetes which potentially eliminates the need for daily insulin injections will commence in New Zealand by Australian company Living Cell Technologies (LCT) . In a trial currently underway in Russia by LCT, two patients are free of requiring daily insulin injections after receiving a Diabecell implant. However, Australian diabetics will have to wait as a result of a moratorium in place by the Australian Government on the technology behind Diabecell. Diabecell are pig cells that produce insulin and when implanted into the abdomen have been shown to lead to near-normal blood glucose levels in patients and the need for insulin injections to be reduced or eliminated. The Australian Government imposed a five year moratorium on xenotransplantation in 2004, prohibiting the transplantation of organs or cells from animals to humans until more information is available about possible health risks. The moratorium is similar to restrictions placed on stem cell research in Australia, an area now well recognized as being essential to future health management. A clear benefit of LCT's technology is that the cells are completely encapsulated and are hidden from the immune system and therefore don't cause an immune rejection. In light of the compelling results on diabetics participating in trials elsewhere in the world, Australian doctors are now calling for the Australian government to review its position on the moratorium. Professor John Dwyer, Clinical Immunologist and Emeritus Professor at the University of New South Wales said the start of the New Zealand diabetes trial marks an important development for the Australian scientific and medical community. "The safe transplantation of insulin producing cells would offer us by far the best technique for controlling diabetes in millions of sufferers globally. These clinical trials are essential as there is no other way of studying the potential benefits except by transplanting these cells into humans." "This technique has enormous potential to reduce suffering and the enormous costs involved in treating diabetes and its many complications. The approval of this trial in New Zealand will hopefully lead to a reconsideration of the current moratorium on xenotransplantation in Australia. Given the safety data now available I am convinced the Australian Government should lift its ban on Australian clinical researchers doing similar trials. We have many leaders in the field in Australia ready to contribute to the global effort to cure diabetes," Professor Dwyer said. The New Zealand Health Minister, the Honourable Tony Ryall, announced today his approval for the Diabecell trial to commence at the Middlemore Hospital, Auckland, immediately. More than 200 diabetics have already been screened to participate, with LCT aiming to involve eight people on the trial which is expect to run for two years. Founder of LCT and diabetes specialist Prof. Bob Elliott said: "We have great hopes for these trials. We already have two patients in the Russian trials that are now off insulin and we are planning to use much higher doses of our product Diabecell in these trials." "Whilst the trials of Diabecell are on our doorstep, Australians will not be able to participate in them because of a current moratorium banning this type of research. We hope that the Australian government will now review its position on our technology and have renewed confidence of the potential value of Diabecell in significantly improving the lives of people living with diabetes." According to the International Diabetes Federation, there are currently around 890,000 Australians who suffer from type 1 and type 2 diabetes, with an additional 3.2 million Australians living with pre-diabetes. <a style="font-weight:normal" href="http://www.lctglobal.com">http://www.lctglobal.com</a> b2bc1035-1742-48e9-85e7-e557694acb43|1|4.0 Posted in: Drug Trial News | Medical Condition News Tags: Diabetes , Insulin , Type 1 Diabetes Permalink | Comments (0) addthis_pub = 'azonetwork'; Related posts Sydney student solves piece of the diabetes puzzle An important piece in the diabetes puzzle which has perplexed scientists for decades has been uncove... Matrix registry probes adherence to clopidogrel at 1 year A large community-based registry of patients treated with drug-eluting stents is providing important... Adult stem cells play no role in insulin production Diabetes researchers, investigating how the body supplies itself with insulin, discovered to their s... Add comment Cancel reply to comment Name* Please choose another name Required E-mail* (Will show your Gravatar icon) Required Please enter a valid e-mail Website Please enter a valid URL Country [Not specified] Albania Algeria Argentina Armenia Australia Austria Azerbaijan Bahrain Bangladesh Belarus Belgium Belize Bolivia Bosnia and Herzegovina Brazil Brunei Darussalam Bulgaria Canada Caribbean Chile Colombia Costa Rica Croatia Czech Republic Denmark Dominican Republic Ecuador Egypt El Salvador Estonia Faroe Islands Finland France Georgia Germany Greece Guatemala Honduras Hong Kong S.A.R. Hungary Iceland India Indonesia Iran Iraq Ireland Islamic Republic of Pakistan Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Korea Kuwait Kyrgyzstan Latvia Lebanon Libya Liechtenstein Lithuania Luxembourg Macao S.A.R. Macedonia (FYROM) Malaysia Maldives Malta Mexico Mongolia Morocco Netherlands New Zealand Nicaragua Norway Oman Panama Paraguay People's Republic of China Peru Philippines Poland Portugal Principality of Monaco Puerto Rico Qatar Republic of the Philippines Romania Russia Saudi Arabia Serbia Singapore Slovakia Slovenia South Africa Spain Sweden Switzerland Syria Taiwan Thailand Trinidad and Tobago Tunisia Turkey U.A.E. Ukraine United Kingdom United States Uruguay Uzbekistan Venezuela Vietnam Yemen Zimbabwe b i u quote Required Comment Preview Comment Notify me when new comments are added GA_googleFillSlot("News-Medical160x600Towers"); Search Medical News Cloud Breast Cancer Cancer Cardiovascular Disease Chemotherapy Diabetes Genetics Genomics Global Health Aid H1N1 Health Disparities Health Insurance Health IT Health Reform HIV/AIDS Hospital Hypertension (High Blood Pressure) Immunology Influenza Malaria Medicaid Medical Legislation Medicare Neurology Nutrition Obesity Oncology Pandemic Pediatrics Pregnancy Prescription Drug Prostate Cancer Seniors Sleep Sleep Disorder Stem Cell Swine Flu Taxation Tuberculosis Vaccine Virus Recent Articles Telehealth Solutions launches CardioPod for NHS Health Check Research investigates DNA of sleep Americans come up with first swine flu vaccine Underweight and extremely obese die earlier Intervention strategies to curb spread of pandemic flu Telemedicine stroke program provides woman a lifeline ADHD genes found - missing DNA segments may suggest future drug targets Researchers to reveal the underlying causes of ageing New breast biopsy technique The pursuit of genetic happiness GA_googleFillSlot("News-Medical728x90Bottom"); // // // _uacct = "UA-2148155-2"; urchinTracker(); var sc_project=759049; var sc_invisible=0; var sc_partition=6; var sc_security="86c97c35"; _qacct="p-44YZJYpg6LiCA";quantserve(); //

Click here to visit inline page

Follow Ups:

Re: NZ Approval for LCT Clinical Trials now Final - payday loans 06:26:35 2010/07/06 (0)
Re: NZ Approval for LCT Clinical Trials now Final - VigRx Plus 16:20:30 2010/05/12 (0)
Re: NZ Approval for LCT Clinical Trials now Final - Drug Rehab Centers 07:11:17 2010/05/10 (0)
VigRx Plus/ - VigRx Plus 10:54:08 2010/04/25 (0)
Re: NZ Approval for LCT Clinical Trials now Final - Nick D 09:47:21 2010/04/11 (0)
Re: NZ Approval for LCT Clinical Trials now Final - Free Microsoft Points 12:37:09 2010/02/09 (0)
Re: NZ Approval for LCT Clinical Trials now Final - Vigrx Plus 00:59:25 2009/12/09 (0)
Health - Saini 23:05:57 2009/11/09 (0)
Re: NZ Approval for LCT Clinical Trials now Final - Tom 02:59:09 2009/09/24 (0)
Re: NZ Approval for LCT Clinical Trials now Final - Clayton 10:57:03 2009/09/11 (0)
Re: NZ Approval for LCT Clinical Trials now Final - Hsa 15:47:14 2009/08/26 (0)
Re: NZ Approval for LCT Clinical Trials now Final - chri12 13:44:06 2009/08/13 (0)
Re: NZ Approval for LCT Clinical Trials now Final - chakru 10:42:28 2009/08/12 (0)
Re: Living Cell Technologies' diabetes clinical trial authorized by New Zealand Government - nzDoctor 09:05:41 2009/06/24 (0)

Post a Followup

[ Follow Ups ] [ Post Followup ] [ The Islet Foundation Public Message Forum ]

Name:
E-Mail: (Optional)
Subject:
Comments:
Link URL: (Optional)
Link Title:
Image URL: (Optional)